# Lymphocyte Reconstitution After Administration of Pegfilgrastim Versus Filgrastim After Peripheral Stem Cell Transplantation

> **NCT01541072** · NA · TERMINATED · sponsor: **Centre Leon Berard** · enrollment: 34 (actual)

## Conditions studied

- Non Hodgkin Lymphoma

## Interventions

- **DRUG:** Pegfilgrastim
- **DRUG:** Filgrastim

## Key facts

- **NCT ID:** NCT01541072
- **Lead sponsor:** Centre Leon Berard
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-02
- **Primary completion:** 2014-06
- **Final completion:** 2014-09
- **Target enrollment:** 34 (ACTUAL)
- **Why stopped:** Number of enrolled patients was insufficient during planned inclusion time.
- **Last updated:** 2016-11-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01541072

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01541072, "Lymphocyte Reconstitution After Administration of Pegfilgrastim Versus Filgrastim After Peripheral Stem Cell Transplantation". Retrieved via MORVS 2026-10-12 from https://api.morvs.ai/clinical/NCT01541072. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*